Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Klimkait

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
Archives of Virology|December 18, 1998
Dissecting the mode of action of various HIV-inhibitor classes in a stable cellular systemT Klimkait, F Stauffer, E Lupo, et al.
Nucleic Acids Research|June 5, 1998
TAR-RNA binding by HIV-1 Tat protein is selectively inhibited by its L-enantiomerA Garbesi, F Hamy, M Maffini, et al.
Bioorganic & Medicinal Chemistry|December 7, 2002
Solid-phase synthesis of diamine and polyamine amino acid derivatives as HIV-1 tat-TAR binding inhibitorsG Jimenez Bueno, T Klimkait, I H Gilbert, et al.
HIV Medicine|January 26, 2008
Detection of drug-resistant HIV minorities in clinical specimens and therapy failureS Louvel, M Battegay, P Vernazza, et al.
Prostate Cancer and Prostatic Diseases|March 29, 2003
Specific block of androgen receptor activity by antisense oligonucleotidesF Hamy, V Brondani, R Spoerri, et al.
Virchows Archiv : an International Journal of Pathology|November 30, 2000
Fetal varicella syndrome: disruption of neural development and persistent inflammation of non-neural tissuesE Bruder, J Ersch, G Hebisch, et al.
Biochemistry|May 16, 1998
A new class of HIV-1 Tat antagonist acting through Tat-TAR inhibitionF Hamy, V Brondani, A Flörsheimer, et al.
Journal of Virology|February 1, 1990
The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and releaseT Klimkait, K Strebel, M D Hoggan, et al.
Chemistry & Biology|September 12, 2000
Blocking HIV replication by targeting Tat proteinF Hamy, N Gelus, M Zeller, et al.
Bioorganic & Medicinal Chemistry|July 31, 1999
Inhibition of HIV-1 Tat-TAR interaction by diphenylfuran derivatives: effects of the terminal basic side chainsN Gelus, C Bailly, F Hamy, et al.
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Archives of Virology|December 18, 1998
Dissecting the mode of action of various HIV-inhibitor classes in a stable cellular systemT Klimkait, F Stauffer, E Lupo, et al.
Nucleic Acids Research|June 5, 1998
TAR-RNA binding by HIV-1 Tat protein is selectively inhibited by its L-enantiomerA Garbesi, F Hamy, M Maffini, et al.
Bioorganic & Medicinal Chemistry|December 7, 2002
Solid-phase synthesis of diamine and polyamine amino acid derivatives as HIV-1 tat-TAR binding inhibitorsG Jimenez Bueno, T Klimkait, I H Gilbert, et al.
HIV Medicine|January 26, 2008
Detection of drug-resistant HIV minorities in clinical specimens and therapy failureS Louvel, M Battegay, P Vernazza, et al.
Prostate Cancer and Prostatic Diseases|March 29, 2003
Specific block of androgen receptor activity by antisense oligonucleotidesF Hamy, V Brondani, R Spoerri, et al.
Virchows Archiv : an International Journal of Pathology|November 30, 2000
Fetal varicella syndrome: disruption of neural development and persistent inflammation of non-neural tissuesE Bruder, J Ersch, G Hebisch, et al.
Biochemistry|May 16, 1998
A new class of HIV-1 Tat antagonist acting through Tat-TAR inhibitionF Hamy, V Brondani, A Flörsheimer, et al.
Journal of Virology|February 1, 1990
The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and releaseT Klimkait, K Strebel, M D Hoggan, et al.
Chemistry & Biology|September 12, 2000
Blocking HIV replication by targeting Tat proteinF Hamy, N Gelus, M Zeller, et al.
Bioorganic & Medicinal Chemistry|July 31, 1999
Inhibition of HIV-1 Tat-TAR interaction by diphenylfuran derivatives: effects of the terminal basic side chainsN Gelus, C Bailly, F Hamy, et al.
Pageof 6